文件类型：PDF/Adobe Acrobat 文件大小：字节
国际学术期刊的论文发表
Dr. Bill Summerskill
《柳叶刀(The Lancet)》执行编辑
Trusted. Timely. Today's Medicine.
Aim 目的
To make manuscript submission clearer and
easier 使投稿更清楚,更容易
To present an editor's view of publishing pitfalls
了解编辑眼中的论文缺陷及如何避免
To encourage you to submit to The Lancet and
elsewhere
鼓励向《柳叶刀(The Lancet)》及其他国际期刊投稿
Aim 目的
Objectives 目标
To use ICMJE guidelines & appreciate their
importance 应用ICMJE指南并理解其重要性
To design appropriate studies to answer your
research question 合理设计试验,解释研究假设
To make your submission as strong as possible
使提交的论文尽可能无懈可击
Afternoon session
Critical appraisal for authors
International standards for reporting
Why publish -
positives
Probity
Professional
Personal
Why publish -
negatives
Time
Criticism
Judgment
Rejection
Publication as a group
exercise
Colleagues
Sponsors
Peers
Editors
The key to successful
publication
Answering the right question at the right time
Clinical importance
Novelty
Using appropriate methodology rigorously
ICMJE
International Committee of Medical Journal
Editors国际医学期刊编辑委员会
Annals, BMJ, CMAJ, JAMA, NEJM, Lancet
Norway, Denmark, Holland, Croatia, NZ,
Australia 挪威,丹麦,荷兰,克罗地亚,新西兰,
澳大利亚
U.S. National Library of Medicine 美国国家医
ICMJE
Uniform Requirements for Manuscripts
Submitted to Biomedical Journals:
Writing and Editing for Biomedical
Publication
按照稿件格式的统一要求向生物医学期刊投稿:生物医学
期刊的写作和编辑
2006年2月
Purpose目的
Ethics 规范
Protection of subjects 保护受试者
ICMJE 生物医学期刊的写作和编辑
Ethics committee
Informed consent
Protocol adherence
Duty of care
Protection of subjects 保护受试
者
Purpose
Ethics
Protection of subjects
Authorship 著作权
ICMJE 生物医学期刊的写作和编辑
Substantial contributions to conception and
design, or acquisition of data, or analysis
and interpretation of data
Drafting the article or revising it critically
for important intellectual content
Final approval of the version to be
published
Who is an Author 著作权
Someone who is prepared to take
personal responsibility and stake his or
her reputation on the integrity of the
research
Who is an Author 著作权
Purpose
Ethics
Protection of subjects
Authorship
Conflicts of interest 利益冲突
ICMJE 生物医学期刊的写作和编辑
Conflict of interest 利益冲突
Financial
Personal
Philosophical
Who can have conflict of
interest
Author
Sponsor
Department
Institution
Peer reviewer
Editor
Journal
Advertiser
利益冲突
Why do conflicts of interest
matter
Bias
利益冲突
Misconduct
Any where
Any time
Any form
Tragedy
Misconduct consequences
Individual
Co-authors
Journal
Science
Society
Misconduct obligations for
journals
Verify
COPE
Local institution
Investigation
Publication
Clinical trials
Registration
Reporting standards
CONSORT, STARD
Respect your data
临床试验
注册
报告的标准
CONSORT,
STARD
忠实于自己的数据
ICMJE 生物医学期刊的写作和编辑
Research design 研究设计
Most important step 事先请教统计学专
家
Consult a statistician beforeyou
start 了解不同方法的优势及局限性
Consider Lancet protocol review or
similar 坚持所选用的方法
Be aware of the strengths and limitations
of different approaches
Be faithful to the methodology chosen
Follow the protocol
Respect your data 遵守相关协议
Research design 研究设计
Submission -where
Who is your reader
International vs.regional
General vs.specialist
Be familiar with your chosen journal
Philosophy
Interests
Submission -where
Reporting style, abstract structure, length
Supporting documents (protocol)
If in doubt, ask
Submission -where
Submission -how 投稿
Cover letter 投稿信
Be brief 简洁
Why manuscript is important to this
readership说明稿件对读者的重要性
Any relevant context 写明有关背景
Appeals 请求
Submission -what
Journals publish more than research
Correspondence
Clinical cases, pictures
Reviews of books, conferences, media
《柳叶刀(The Lancet)》的宗旨
Thomas Wakley, 1828年
传递知识
不断更新
享受知识
Independence 独立
World view 面向全世
界
Critical debate
敢于批评与争鸣
Medicine as a
culture 医学是一种文
《柳叶刀(The Lancet)》的价值观
Protocol review 协议审
阅
Fast Track 快速追踪
Website 网站
Press office 印务办事处
Local editions 本地版
《柳叶刀(The Lancet)》的服务
Protocol review 协议审
阅
Fast Track 快速追踪
Website 网站
Press office 印务办事处
Local editions 本地版
《柳叶刀(The Lancet)》的服务
向《柳叶刀(The Lancet)》投稿
蓝:述评,通讯,ADR等
红:论文
绿:综述,学术讨论会,系列讲座,假说,观点,`
病例报告,临床现象,公共卫生,评论
http://www.thelancet.com/authors/lancet/authorinfo
http://ees.elsevier.com/thelancet
Articles 论文
Original research that is likely to change clinical
practice or thinking about a disease
对某一疾病临床医疗可能产生改变或再
认识的原创性论文
'First and last'"第一和最后"
Phase I trials I 期临床试验
Meta-analyses Meta-分析
The Lancetfamily
journals
The Lancetfamily
journals
The Lancetfamily
journals
The Lancetfamily
journals
The Lancetfamily
journals
Article
Article (RCT)
Case report
Fast track
Fast track (RCT)
FT to NT articles
Other
Comments
View point
Unsolicited
rev/sem /ser
Invited rev/sem /ser
Submissions 各类稿件的情况
AFRICA
ASIA
AUSTRALASIA
W.EUROPE
S.AMERICA
M.EAST
RUSSIA
UKCAN & N. USA
E.EUROPE
JAPAN
CARIBBEAN
AND CENTRAL
USA
Submissions 各类稿件的情况
Manuscripts
Electronic submission
http://ees.elsevier.com
/thelancet
Internal review
1/3 rejected outright
Assigned to specialist editor
Rejected papers given a third senior read
'Rescue'option
Peer review
Recent, Unproven
At least 3 clinical (1 from authors'country)
& 1 stats
Fast track vs normal track
Remuneration
Fraud
Manuscripts
100 submitted
20 peer-reviewed80 rejected
8 revised12 rejected
4 accepted4 rejected
Pre acceptance
Revised manuscript
±Re-review
Signatures
Author contributions
Conflict of interest statements
Editorial consensus
Post acceptance
Copyright
Subediting and editing
Comment
Press release
Podcast
Publication embargo
Post acceptance
Access
www.thelancet.com
Free
Institutional website (word doc)
Correspondence
2006年1月29日～2007年2月17日中国稿件投稿总数
投稿数170
9253
同行评议19 (11%)
2027 (22%)
接受5 (3%)
中国的投稿情况:
2 200 000 Doctors
Massive investment in Research &
Development
80 000 Publications
Studies on an unparalleled scale
China's solutions to care for an aging
population will inform practice around
中国的投稿情况:
Top 1% medical schools
5thfor science
中国的投稿情况:Beijing
University
"…中国有可能在世界领先,不
仅是研究数量,而且是质量."
The Lancet
369: 880 (March 17, 2007)
中国的投稿情况:
Self-interest
Open Publication
Do Journals have a future
Journals are changing
Peer review
Web
Access
Blogs, Podcasts, RSS
Do Journals have a future
Paper will become less common
More information will be available on-line
Protocol, original data
Easier access
Research will become more sophisticated
Do Journals have a future
Do Journals have a future
Dr. Bill Summerskill
《柳叶刀(The Lancet)》执行编辑
Trusted. Timely. Today's Medicine.
Aim 目的
To make manuscript submission clearer and
easier 使投稿更清楚,更容易
To present an editor's view of publishing pitfalls
了解编辑眼中的论文缺陷及如何避免
To encourage you to submit to The Lancet and
elsewhere
鼓励向《柳叶刀(The Lancet)》及其他国际期刊投稿
Aim 目的
Objectives 目标
To use ICMJE guidelines & appreciate their
importance 应用ICMJE指南并理解其重要性
To design appropriate studies to answer your
research question 合理设计试验,解释研究假设
To make your submission as strong as possible
使提交的论文尽可能无懈可击
Afternoon session
Critical appraisal for authors
International standards for reporting
Why publish -
positives
Probity
Professional
Personal
Why publish -
negatives
Time
Criticism
Judgment
Rejection
Publication as a group
exercise
Colleagues
Sponsors
Peers
Editors
The key to successful
publication
Answering the right question at the right time
Clinical importance
Novelty
Using appropriate methodology rigorously
ICMJE
International Committee of Medical Journal
Editors国际医学期刊编辑委员会
Annals, BMJ, CMAJ, JAMA, NEJM, Lancet
Norway, Denmark, Holland, Croatia, NZ,
Australia 挪威,丹麦,荷兰,克罗地亚,新西兰,
澳大利亚
U.S. National Library of Medicine 美国国家医
ICMJE
Uniform Requirements for Manuscripts
Submitted to Biomedical Journals:
Writing and Editing for Biomedical
Publication
按照稿件格式的统一要求向生物医学期刊投稿:生物医学
期刊的写作和编辑
2006年2月
Purpose目的
Ethics 规范
Protection of subjects 保护受试者
ICMJE 生物医学期刊的写作和编辑
Ethics committee
Informed consent
Protocol adherence
Duty of care
Protection of subjects 保护受试
者
Purpose
Ethics
Protection of subjects
Authorship 著作权
ICMJE 生物医学期刊的写作和编辑
Substantial contributions to conception and
design, or acquisition of data, or analysis
and interpretation of data
Drafting the article or revising it critically
for important intellectual content
Final approval of the version to be
published
Who is an Author 著作权
Someone who is prepared to take
personal responsibility and stake his or
her reputation on the integrity of the
research
Who is an Author 著作权
Purpose
Ethics
Protection of subjects
Authorship
Conflicts of interest 利益冲突
ICMJE 生物医学期刊的写作和编辑
Conflict of interest 利益冲突
Financial
Personal
Philosophical
Who can have conflict of
interest
Author
Sponsor
Department
Institution
Peer reviewer
Editor
Journal
Advertiser
利益冲突
Why do conflicts of interest
matter
Bias
利益冲突
Misconduct
Any where
Any time
Any form
Tragedy
Misconduct consequences
Individual
Co-authors
Journal
Science
Society
Misconduct obligations for
journals
Verify
COPE
Local institution
Investigation
Publication
Clinical trials
Registration
Reporting standards
CONSORT, STARD
Respect your data
临床试验
注册
报告的标准
CONSORT,
STARD
忠实于自己的数据
ICMJE 生物医学期刊的写作和编辑
Research design 研究设计
Most important step 事先请教统计学专
家
Consult a statistician beforeyou
start 了解不同方法的优势及局限性
Consider Lancet protocol review or
similar 坚持所选用的方法
Be aware of the strengths and limitations
of different approaches
Be faithful to the methodology chosen
Follow the protocol
Respect your data 遵守相关协议
Research design 研究设计
Submission -where
Who is your reader
International vs.regional
General vs.specialist
Be familiar with your chosen journal
Philosophy
Interests
Submission -where
Reporting style, abstract structure, length
Supporting documents (protocol)
If in doubt, ask
Submission -where
Submission -how 投稿
Cover letter 投稿信
Be brief 简洁
Why manuscript is important to this
readership说明稿件对读者的重要性
Any relevant context 写明有关背景
Appeals 请求
Submission -what
Journals publish more than research
Correspondence
Clinical cases, pictures
Reviews of books, conferences, media
《柳叶刀(The Lancet)》的宗旨
Thomas Wakley, 1828年
传递知识
不断更新
享受知识
Independence 独立
World view 面向全世
界
Critical debate
敢于批评与争鸣
Medicine as a
culture 医学是一种文
《柳叶刀(The Lancet)》的价值观
Protocol review 协议审
阅
Fast Track 快速追踪
Website 网站
Press office 印务办事处
Local editions 本地版
《柳叶刀(The Lancet)》的服务
Protocol review 协议审
阅
Fast Track 快速追踪
Website 网站
Press office 印务办事处
Local editions 本地版
《柳叶刀(The Lancet)》的服务
向《柳叶刀(The Lancet)》投稿
蓝:述评,通讯,ADR等
红:论文
绿:综述,学术讨论会,系列讲座,假说,观点,`
病例报告,临床现象,公共卫生,评论
http://www.thelancet.com/authors/lancet/authorinfo
http://ees.elsevier.com/thelancet
Articles 论文
Original research that is likely to change clinical
practice or thinking about a disease
对某一疾病临床医疗可能产生改变或再
认识的原创性论文
'First and last'"第一和最后"
Phase I trials I 期临床试验
Meta-analyses Meta-分析
The Lancetfamily
journals
The Lancetfamily
journals
The Lancetfamily
journals
The Lancetfamily
journals
The Lancetfamily
journals
Article
Article (RCT)
Case report
Fast track
Fast track (RCT)
FT to NT articles
Other
Comments
View point
Unsolicited
rev/sem /ser
Invited rev/sem /ser
Submissions 各类稿件的情况
AFRICA
ASIA
AUSTRALASIA
W.EUROPE
S.AMERICA
M.EAST
RUSSIA
UKCAN & N. USA
E.EUROPE
JAPAN
CARIBBEAN
AND CENTRAL
USA
Submissions 各类稿件的情况
Manuscripts
Electronic submission
http://ees.elsevier.com
/thelancet
Internal review
1/3 rejected outright
Assigned to specialist editor
Rejected papers given a third senior read
'Rescue'option
Peer review
Recent, Unproven
At least 3 clinical (1 from authors'country)
& 1 stats
Fast track vs normal track
Remuneration
Fraud
Manuscripts
100 submitted
20 peer-reviewed80 rejected
8 revised12 rejected
4 accepted4 rejected
Pre acceptance
Revised manuscript
±Re-review
Signatures
Author contributions
Conflict of interest statements
Editorial consensus
Post acceptance
Copyright
Subediting and editing
Comment
Press release
Podcast
Publication embargo
Post acceptance
Access
www.thelancet.com
Free
Institutional website (word doc)
Correspondence
2006年1月29日～2007年2月17日中国稿件投稿总数
投稿数170
9253
同行评议19 (11%)
2027 (22%)
接受5 (3%)
中国的投稿情况:
2 200 000 Doctors
Massive investment in Research &
Development
80 000 Publications
Studies on an unparalleled scale
China's solutions to care for an aging
population will inform practice around
中国的投稿情况:
Top 1% medical schools
5thfor science
中国的投稿情况:Beijing
University
"…中国有可能在世界领先,不
仅是研究数量,而且是质量."
The Lancet
369: 880 (March 17, 2007)
中国的投稿情况:
Self-interest
Open Publication
Do Journals have a future
Journals are changing
Peer review
Web
Access
Blogs, Podcasts, RSS
Do Journals have a future
Paper will become less common
More information will be available on-line
Protocol, original data
Easier access
Research will become more sophisticated
Do Journals have a future
Do Journals have a future
·上一篇：C++课程设计指导书
·下一篇：关于佛教文化发展情况的论文